Kyle R. Cowdrick

Kyle R. Cowdrick

Auto-generated profile, based on publicly available information

Kyle R. Cowdrick

Georgia Institute of Technology and Emory University, Wallace H. Coulter Department of Biomedical Engineering, Atlanta, Georgia, United States

Research Focus & Metrics

Representative Publications

View All Publications
30 August 2022 in Neurophotonics
Verified
Journal Article
Open access
PDF file
Hasan AyazHasan Ayaz
Hasan Ayaz
Wesley BakerWesley Baker
Wesley Baker
GBGiles Blaney
Giles Blaney
DBDavid A. Boas
David A. Boas
Heather BortfeldHeather Bortfeld
Heather Bortfeld
WZWenjun Zhou
Wenjun Zhou
We have come a long way since Jöbsis first demonstrated that noninvasive cerebral monitoring was possible in humans within the near-infrared light window (approximately 700 to 1000 nm) in the late 1970s.1 What started as a tool to quantify blood oxygenation in the brain has exploded into a whole field of study that aims to exploit this window to reveal a battery of information related to human brain physiology, including brain metabolism, blood flow, autoregulation, perfusion pressure, water concentration, light scattering, exogenous contrast agents, and more. In this text, we use the term “diffuse optics” to broadly describe any technique that employs a near-infrared light source and a photodetector to capture multiply scattered photons in the diffusion limit (i.e., in the limit wherein the absorption coefficient, μa, is much less than the reduced scattering coefficient, μs′, and the source-detector separation is much greater than the photon mean free path). The term “diffuse” has historical connotations in the field and reflects how near-infrared photons propagate through biological tissue. However, it should be noted that this term is in no way associated with how the field/community is organized or conducts its science. On the contrary, the breadth and depth of the progress made in the field over the past decade could only be accomplished by a cohesive, focused, and tight-knit community of researchers!

24 September 2021 in Military Medicine
Verified
Journal Article
Open access
PDF file
JWJulia L.A Woodall
Julia L.A Woodall
JSJordyn a Sak
Jordyn a Sak
KCKyle R Cowdrick
Kyle R Cowdrick
BMBrady M Bove Muñoz
Brady M Bove Muñoz
JMJessica h McElrath
Jessica h McElrath
CHCharles R Hutchinson
Charles R Hutchinson
Occupational exposure to repetitive, low-level blasts in military training and combat has been tied to subconcussive injury and poor health outcomes for service members. Most low-level blast studies to date have focused on explosive breaching and firing heavy weapon systems; however, there is limited research on the repetitive blast exposure and physiological effects that mortarmen experience when firing mortar weapon systems. Motivated by anecdotal symptoms of mortarmen, the purpose of this paper is to characterize this exposure and its resulting neurocognitive effects in order to provide preliminary findings and actionable recommendations to safeguard the health of mortarmen. In collaboration with the U.S. Army Rangers at Fort Benning, blast exposure, symptoms, and pupillary light reflex were measured during 3 days of firing 81 mm and 120 mm mortars in training. Blast exposure analysis included the examination of the blast overpressure (BOP) and cumulative exposure by mortarman position, as well as comparison to the 4 psi safety threshold. Pupillary light reflex responses were analyzed with linear mixed effects modeling. All neurocognitive results were compared between mortarmen (n = 11) and controls (n = 4) and cross-compared with blast exposure and blast history. Nearly 500 rounds were fired during the study, resulting in a high cumulative blast exposure for all mortarmen. While two mortarmen had average BOPs exceeding the 4 psi safety limit ( Fig. 2), there was a high prevalence of mTBI-like symptoms among all mortarmen, with over 70% experiencing headaches, ringing in the ears, forgetfulness/poor memory, and taking longer to think during the training week (n ≥ 8/11). Mortarmen also had smaller and slower pupillary light reflex responses relative to controls, with significantly slower dilation velocity (P < 0.05) and constriction velocity (P < 0.10). (A) Swarm scatter chart displaying all blast events for each mortarman on the 120 mm and 81 mm mortars (AG = assistant gunner, G = gunner, SL = squad leader, AB = ammunition bearer). Overlaid with box plots for each. Subjects with means significantly greater than 4 psi are indicated with ***P < 0.001. (B) Blast overpressure (BOP) exposure values for all mortarmen, including FDCs (FDC = fire direction center). Mortarmen experienced high cumulative blast exposure coinciding with altered neurocognition that is suggestive of blast-related subconcussive injury. These neurocognitive effects occurred even in mortarmen with average BOP below the 4 psi safety threshold. While this study was limited by a small sample size, its results demonstrate a concerning health risk for mortarmen that requires additional study and immediate action. Behavioral changes like ducking and standing farther from the mortar when firing can generally help reduce mortarmen BOP exposure, but we recommend the establishment of daily cumulative safety thresholds and daily firing limits in training to reduce cumulative blast exposure, and ultimately, improve mortarmen’s quality of life and longevity in service.

19 August 2019 in Neurophotonics
Verified
Journal Article
Open access
PDF file
SLSeung Yup Lee
Seung Yup Lee
KCKyle R. Cowdrick
Kyle R. Cowdrick
BSBharat Sanders
Bharat Sanders
ESEashani Sathialingam
Eashani Sathialingam
CMCourtney E. McCracken
Courtney E. McCracken
EBErin Buckley
Erin Buckley
Sickle cell disease (SCD) is a genetic blood disorder affecting nearly 300,000 neonates worldwide per year.1 A single mutation in the beta-globin gene produces sickle hemoglobin (HbS), a structural variant of normal adult hemoglobin (HbA). While patients with sickle cell trait who inherit one HbS gene and one HbA gene are typically asymptomatic, individuals who inherit HbS genes from both parents suffer from sickle cell anemia that can cause serious acute and chronic complications in multiple organs.2

1 December 2023 in Journal of Biomedical Optics
Verified
Journal Article
Open access
PDF file
HZHongting Zhao
Hongting Zhao
ESEashani Sathialingam
Eashani Sathialingam
KCKyle R. Cowdrick
Kyle R. Cowdrick
TUTara Urner
Tara Urner
SLSeung Yup Lee
Seung Yup Lee
EBErin Buckley
Erin Buckley
Diffuse correlation spectroscopy (DCS) is a low-cost, non-invasive optical technology for measuring blood flow. DCS measures the temporal intensity autocorrelation (g2(τ)) of multiply scattered light that has traveled from the source to the tissue surface. The decay rate of this curve is related to the motion of red blood cells in the underlying tissue.1,2 Correlation diffusion theory is used to estimate an index of blood flow (cm2/s) from g2(τ). When DCS is applied in the brain, detected photons that carry information about cerebral hemodynamics have also interacted with extracerebral layers (i.e., skull, scalp, and cerebral spinal fluid) by the nature of the non-invasive measurement. Thus, signal contamination from extracerebral layers is a challenge with DCS.3,4

1 April 2025 in Neurophotonics
Verified
Journal Article
Open access
LRLucas Kreiß Roohian
Lucas Kreiß Roohian
MWMelissa Wu
Melissa Wu
MWMichael Wayne
Michael Wayne
SXShiqi Xu
Shiqi Xu
PMPaul McKee
Paul McKee
RHRoarke Horstmeyer
Roarke Horstmeyer
SignificanceDiffuse correlation spectroscopy (DCS) allows label-free, non-invasive investigation of microvascular dynamics deep within tissue, such as cerebral blood flow (CBF). However, the signal-to-noise ratio (SNR) in DCS limits its effective cerebral sensitivity in adults, in which the depth to the brain, through the scalp and skull, is substantially larger than in infants.AimTherefore, we aim to increase its SNR and, ultimately, its sensitivity to CBF through new DCS techniques.ApproachWe present an in vivo demonstration of parallelized DCS (PDCS) to measure cerebral and muscular blood flow in healthy adults. Our setup employs an innovative array with hundreds of thousands single photon avalanche diodes (SPAD) in a 500×500 grid to boost SNR by averaging all independent pixel measurements. We tested this device on different total pixel counts and frame rates. A secondary, smaller array was used for reference measurements from shallower tissue at lower source-detector-separation (SDS).ResultsThe new system can measure pulsatile blood flow in cerebral and muscular tissue, at up to 4 cm SDS, while maintaining a similar measurement noise as compared with a previously published 32×32 PDCS system at 1.5 cm SDS. Data from a cohort of 15 adults provide strong experimental evidence for functional CBF activity during a cognitive memory task and allowed analysis of pulse markers. Additional control experiments on muscular blood flow in the forearm with a different technical configuration provide converging evidence for the efficacy of this technique.ConclusionsOur results outline successful PDCS measurements with large SPAD arrays to enable detect CBF in human adults. The ongoing development of SPAD camera technology is expected to result in larger and faster detectors in the future. In combination with new data processing techniques, tailored for the sparse signal of binary photon detection events in SPADs, this could lead to even greater SNR increase and ultimately greater depth sensitivity of PDCS.

1 April 2023 in Neurophotonics
Verified
Journal Article
Open access
PDF file
KCKyle R. Cowdrick
Kyle R. Cowdrick
TUTara Urner
Tara Urner
ESEashani Sathialingam
Eashani Sathialingam
ZFZhou Fang
Zhou Fang
AQAyesha Quadri
Ayesha Quadri
EBErin Buckley
Erin Buckley
SignificanceCerebrovascular reactivity (CVR), i.e., the ability of cerebral vasculature to dilate or constrict in response to vasoactive stimuli, is a biomarker of vascular health. Exogenous administration of inhaled carbon dioxide, i.e., hypercapnia (HC), remains the “gold-standard” intervention to assess CVR. More tolerable paradigms that enable CVR quantification when HC is difficult/contraindicated have been proposed. However, because these paradigms feature mechanistic differences in action, an assessment of agreement of these more tolerable paradigms to HC is needed.AimWe aim to determine the agreement of CVR assessed during HC, breath-hold (BH), and resting state (RS) paradigms.ApproachHealthy adults were subject to HC, BH, and RS paradigms. End tidal carbon dioxide (EtCO2) and cerebral blood flow (CBF, assessed with diffuse correlation spectroscopy) were monitored continuously. CVR (%/mmHg) was quantified via linear regression of CBF versus EtCO2 or via a general linear model (GLM) that was used to minimize the influence of systemic and extracerebral signal contributions.ResultsStrong agreement (CCC ≥ 0.69; R ≥ 0.76) among CVR paradigms was demonstrated when utilizing a GLM to regress out systemic/extracerebral signal contributions. Linear regression alone showed poor agreement across paradigms (CCC ≤ 0.35; R ≤ 0.45).ConclusionsMore tolerable experimental paradigms coupled with regression of systemic/extracerebral signal contributions may offer a viable alternative to HC for assessing CVR.